Stinging insect allergy

Medical Journal of Australia

Volumn 171, Issue 11-12, 1999, Pages 649-650

  O'Hehir, Robyn E ^a   Douglass, Jo A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLAXIS; ATOPY; CROSS REACTION; DELAYED HYPERSENSITIVITY; HYMENOPTERA; IMMUNOTHERAPY; INSECT ALLERGY; RISK ASSESSMENT; SHORT SURVEY;

EID: 0033530649     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1999.tb123835.x     Document Type: Short Survey

References (17)

1. Donovan GR, Baldo BA, Sutherland S. Molecular cloning and characterisation of a major allergen (Myr p 1) from the venom of the Australian jumper ant. Biochim Biophys Acta 1993; 1171: 272-280.
2. Stuckey M, Cobain T, Sears M, et al. Bee venom hypersensitivity in Busselton [letter]. Lancet 1982; 2: 41.
3. Harvey P, Sperber S, Kette F, et al. Bee-sting mortality in Australia. Med J Aust 1984; 140: 209-211.
4. Douglas RG, Weiner JM, Abramson MJ, O'Hehir RE. Prevalence of severe ant-venom allergy in southeastern Australia. J Allergy Clin Immunol 1998; 101: 129-131.
5. Reisman RE. Clinical aspects of hymenoptera allergy. In: Levine MI, Lockey RF, editors. Monograph on insect allergy. Pittsburgh: Dave Lambert Associates, 1995: 39-42.
6. Toogood JH. Risk of anaphylaxis in patients receiving beta-blocker drugs. J Allergy Clin Immunol 1988; 81: 1-5
7. Golden DBK, Marsh DG, Kagey-Sobotka A, et al. Epidemiology of insect venom sensitivity. JAMA 1989; 262: 240-244.
8. Muller UR. Immunotherapy of insect venom allergy - state of the art. ACI Int 1997; 9: 180-184.
9. Glaspole I, Douglass JA, Czarny D, O'Hehir RE. Stinging insect allergies: assessing and managing. Aust Fam Physician 1997; 26: 1395-1399.
10. Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986; 78: 76-83.
11. Douglas RG, O'Hehir RE. Peanut allergy. Education, avoidance and adrenaline are the mainstays of management. Med J Aust 1997; 166: 63-64.
12. Reisman RE. Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions. J Allergy Clin Immunol 1992; 90: 335-339.
13. Thoracic Society of Australia and New Zealand and Australasian Society of Clinical Immunology. Specific allergen immunotherapy for asthma [position statement]. Med J Aust 1997; 167: 540-544.
14. Dent O. Clinical workforce in internal medicine and paediatrics in Australia, 1997. Fellowship Aff 18: 31-40.
15. Jutel M, Pichler WJ, Skrbic D, et al. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol 1995; 154: 4187-4194.
16. Rolland JM, O'Hehir RE. Immunotherapy of allergy: anergy, deletion and immune deviation. Curr Opin Immunol 1998; 10: 640-645.
17. Muller U, Akdis A, Fricker M, et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998; 101: 747-754.